CNBX Pharmaceuticals Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Eyal Barad
Chief executive officer
US$253.9k
Total compensation
| CEO salary percentage | 89.3% |
| CEO tenure | 6.8yrs |
| CEO ownership | n/a |
| Management average tenure | 5.9yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| May 31 2024 | n/a | n/a | -US$1m |
| Feb 29 2024 | n/a | n/a | -US$1m |
| Nov 30 2023 | n/a | n/a | -US$4m |
| Aug 31 2023 | US$254k | US$227k | -US$4m |
| May 31 2023 | n/a | n/a | -US$4m |
| Feb 28 2023 | n/a | n/a | -US$4m |
| Nov 30 2022 | n/a | n/a | -US$3m |
| Aug 31 2022 | US$269k | US$246k | -US$4m |
| May 31 2022 | n/a | n/a | -US$4m |
| Feb 28 2022 | n/a | n/a | -US$5m |
| Nov 30 2021 | n/a | n/a | -US$4m |
| Aug 31 2021 | US$269k | US$253k | -US$3m |
| May 31 2021 | n/a | n/a | -US$3m |
| Feb 28 2021 | n/a | n/a | -US$3m |
| Nov 30 2020 | n/a | n/a | -US$3m |
| Aug 31 2020 | US$241k | US$222k | -US$7m |
| May 31 2020 | n/a | n/a | -US$8m |
| Feb 29 2020 | n/a | n/a | -US$8m |
| Nov 30 2019 | n/a | n/a | -US$3m |
| Aug 31 2019 | US$276k | US$258k | US$1m |
| May 31 2019 | n/a | n/a | US$2m |
| Feb 28 2019 | n/a | n/a | US$1m |
| Nov 30 2018 | n/a | n/a | -US$4m |
| Aug 31 2018 | US$207k | US$207k | -US$4m |
Compensation vs Market: Eyal's total compensation ($USD253.93K) is below average for companies of similar size in the US market ($USD651.15K).
Compensation vs Earnings: Eyal's compensation has been consistent with company performance over the past year.
CEO
Eyal Barad (59 yo)
6.8yrs
Tenure
US$253,929
Compensation
Mr. Eyal Barad is the Co- Founder of CNBX Pharmaceuticals Inc. (formerly known as Cannabics Pharmaceuticals Inc.) and has been its Chief Executive Officer since January 29, 2018 and Director since November...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.1yrs | US$381.57k | no data | |
| Co-Founder | 6.8yrs | US$253.93k | no data | |
| Chief Financial Officer | 8yrs | US$40.32k | no data | |
| Chief Technology Officer | 2.3yrs | US$48.12k | no data | |
| Vice President of Public Relations & Investor Relations | no data | no data | no data | |
| Senior Advisor of Regulation | 7.7yrs | no data | no data | |
| Financial Advisor & Member of Advisory Board | no data | no data | no data | |
| Chief Data Officer | 6.8yrs | no data | no data | |
| Head of Cannabidiol Research | 4.9yrs | no data | no data | |
| Head of Neuropsychiatry Development | 3.2yrs | no data | no data | |
| Member of Scientific Advisory Board & VP of IP | no data | no data | no data |
5.9yrs
Average Tenure
59yo
Average Age
Experienced Management: CNBX's management team is seasoned and experienced (5.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.1yrs | US$381.57k | no data | |
| Co-Founder | 7yrs | US$253.93k | no data | |
| Senior Advisor of Regulation | 7.7yrs | no data | no data | |
| Financial Advisor & Member of Advisory Board | 7.7yrs | no data | no data | |
| Member of Scientific Advisory Board & VP of IP | no data | no data | no data | |
| Member of Advisory Board | 4.6yrs | no data | no data | |
| Head of Advisory Board | 7.7yrs | US$49.85k | no data | |
| Member of Advisory Board | 7.7yrs | no data | no data | |
| Member of Advisory Board | 4.4yrs | no data | no data | |
| Member of Advisory Board | 4.3yrs | no data | no data | |
| Member of Advisory Board | 3.3yrs | no data | no data | |
| Member of Advisory Board | 3.3yrs | no data | no data |
5.1yrs
Average Tenure
59.5yo
Average Age
Experienced Board: CNBX's board of directors are considered experienced (5.1 years average tenure).